Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Namesake of PF-05231023: how nomenclature confusion leads to experimental misinterpretation in pharmacologic research
    Published on 2025-09-19
    10 months ago
  • Comparative polygenic predispositions of treatment-resistant depression in East Asian and European populations
    Published on 2025-09-19
    10 months ago
  • Effect of caffeine and cannabidiol (CBD) co-administration on Δ9-tetrahydrocannabinol (Δ9-THC) subjective effects, performance impairment, and pharmacokinetics
    Published on 2025-09-17
    10 months ago
  • The exposome and the developing adolescent brain: understanding mechanisms of neuroplasticity
    Published on 2025-09-17
    10 months ago
  • Standing firm: a lived experience perspective on Tourette’s Syndrome
    Published on 2025-09-15
    11 months ago
  • Brainwaves meet soundwaves: ultrasound stimulation for treating major depressive disorder by targeting the subcallosal cingulate cortex
    Published on 2025-09-15
    11 months ago
  • N,N-dimethyltryptamine effects on connectome harmonics, subjective experience and comparative psychedelic experiences
    Published on 2025-09-12
    11 months ago
« Previous 1 … 39 40 41 42 43 … 143 Next »
Journal of Psychopharmacology
  • Into the wild frontier: Mapping the terrain of adverse events in psychedelic-assisted therapies
    Published on 2024-10-30
    2 years ago
  • Co-use of psychedelics with other substances: Findings from the global psychedelic survey
    Published on 2024-10-29
    2 years ago
  • Effects of positive mGlu5 modulation on D2 signaling and nicotine-conditioned place preference: Mechanisms of epigenetic inheritance in a transgenerational model of drug abuse vulnerability in psychosis
    Published on 2024-10-28
    2 years ago
  • Ketamine use in a large global sample: Characteristics, patterns of use and emergency medical treatment
    Published on 2024-10-18
    2 years ago
  • The impact of cannabidiol placebo on amygdala-based neural responses to an acute stressor
    Published on 2024-10-14
    2 years ago
  • Rapid and sustained reduction of treatment-resistant PTSD symptoms after intravenous ketamine in a real-world, psychedelic paradigm
    Published on 2024-10-14
    2 years ago
  • Cognitive effects, pharmacokinetics, and safety of zuranolone administered alone or with alprazolam or ethanol in healthy adults in a phase 1 trial
    Published on 2024-10-12
    2 years ago
« Previous 1 … 39 40 41 42 43 … 150 Next »
European Neuropsychopharmacology
  • Orbitofrontal cortex hypergyrification in hallucinating schizophrenia patients: Surface ratio as a promising brain biomarker
    Published on 2024-09-27
    2 years ago
  • Pioglitazone attenuates behavioral and electrophysiological dysfunctions induced by two-hit model of schizophrenia in adult rodent offspring
    Published on 2024-09-27
    2 years ago
  • Psychiatric first-aid kit: A review of EMA’s critical medicines list
    Published on 2024-09-27
    2 years ago
  • The polarity index of cariprazine
    Published on 2024-09-27
    2 years ago
  • The Transdiagnostic Global Impression – Psychopathology scale (TGI-P): Initial development of a novel transdiagnostic tool for assessing, tracking, and visualising psychiatric symptom severity in everyday practice
    Published on 2024-09-06
    2 years ago
  • The gut-microbiome in adult Attention-deficit/hyperactivity disorder – A Meta-analysis
    Published on 2024-09-06
    2 years ago
  • Effects of antipsychotic treatment on cardio-cerebrovascular related mortality in schizophrenia: A subanalysis of a systematic review and meta-analysis with meta-regression of moderators
    Published on 2024-09-06
    2 years ago
« Previous 1 … 39 40 41 42 43 … 168 Next »

   Pharma Pub